SCHEMBL10124468

SCHEMBL10124468

N#Cc1sc(N2CCOCC2)nc1NC(=O)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.40
PIK3CA P42336 3/20 0.40
PIK3CB P42338 3/20 0.40
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.37
ALOX5 P09917 3/20 0.37
PTGS2 P35354 2/20 0.37
DGAT1 O75907 1/20 0.37
PIN1 Q13526 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PIK3CG P48736 3/20 0.34
ADORA2A P29274 1/20 0.34
LMNA P02545 1/20 0.34
LRRK2 Q5S007 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724907 0.84 PIK3CA (0.45) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL725321 0.81 GAA (0.47) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL20489644 0.69 TRPM8 (0.33) MAPTKMT2A
SCHEMBL724741 0.69 CTSK (0.45) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL3140235 0.69 ALOX15 (0.47) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL3083538 0.64 PIK3CD (0.62) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL15348889 0.64 PIK3CD (0.45) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL2340680 0.63 PIK3CD (0.63) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL12752822 0.62 ALDH1A1 (0.50) PIK3CDPIK3CAPIK3CBALDH1A1SMN1; SMN2
SCHEMBL8553674 0.62 P2RY1 (0.37) ALDH1A1SMN1; SMN2MAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410095-B2 Thiazolopyrimidinone derivatives as PI3 kinase inhibitors GLAXOSMITHKLINE LLC (US) 2013-04-02 US disclosed
US-20120053147-A1 THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS GLAXOSMITHKLINE LLC 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053147-A1 THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS PIK3CD, PIK3CA, PI4KA PIK3CD 1/4885PIK3CA 2/4885PIK3CB 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.